Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Incannex Healthcare Inc. - Common Stock (NQ:IXHL)

0.2726 +0.0126 (+4.85%)
Streaming Delayed Price Updated: 9:59 AM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Incannex Healthcare Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Incannex Starts Phase 2 Clinical Trial Of CBD-Based Drug For Use In Treatment Of Rheumatoid Arthritis ↗
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has commenced a phase 2 clinical trial to assess the safety and efficacy of its proprietary anti-inflammatory combination drug IHL-675A in patients... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket ↗
Gainers Inpixon (NASDAQ: INPX) shares rose 41% to $2.20 in pre-market trading after gaining 6% on Tuesday. Inpixon, last month, secured a purchase order valued at over $1m for its RTLS products from a... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
During Friday's morning session, 234 stocks hit new 52-week lows. Interesting Facts About Today's 52-Week Lows: The largest company in terms of market cap... 
Via Benzinga
News headline image
Australian Psychedelics: Phase 2 Trial On Psilocybin For Anxiety Will Soon Share Results ↗
Australian biopharma company developing therapeutic cannabinoid products and psychedelic medicines Incannex Healthcare (NASDAQ: 
Via Benzinga
News headline image
Psyched: Psychedelic Therapy In The Workplace, UCL's Brain Imaging Study, COMPASS Trials And More ↗
Psychedelic Therapy Now Available As Workplace Benefit, Free Month For Laid-Off Tech Workers 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
We're starting off the day with a look at the biggest pre-market stock movers that traders will want to watch on Thursday! 
Via InvestorPlace
News headline image
Incannex Files A Provisional Patent Application Of Its THC-Based IHL-42X For The Treatment Of Obstructive Sleep Apnea ↗
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL), announced the filing of a provisional patent application directed to the use of IHL-42X for the treatment of obstructive sleep apnea (‘OSA’). 
Via Benzinga
News headline image
Eurofins To Produce Incannex' 2 CBD Medicated Chews For Treatment Of Nicotine And Opioid Addiction Disorders ↗
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has engaged multinational contract development and manufacturing organization Eurofins Scientific (OTCPK:ERFSF) to manufacture Incannex’s two... 
Via Benzinga
News headline image
Incannex Initiates BA/BE Clinical Trial Evaluating IHL-42X In Obstructive Sleep Apnoea ↗
Cannabis and psychedelics-focused Pharma company Incannex Healthcare Limited (NASDAQ: IXHL) (ASX: IHL) initiated a BA/BE study and is targeting submission of an IND application with the FDA in Q1... 
Via Benzinga
News headline image
A Global List Of Cannabis Operators And Executives To Keep An Eye On In 2022 And Beyond ↗
Less than 30 years after Israel became the first nation in the world to allow its citizens to use cannabis for medical purposes, the medical and adult-use cannabis markets have spread across the globe... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Incannex Healthcare (NASDAQ:IXHL) shares moved upwards by 30.7% to $5.19 during Friday's pre-market session. The market value of their outstanding shares is at $316.2 million. 
Via Benzinga
News headline image
Australian Psychedelics: Incannex Business & Financials, New Research Center For Mushrooms & Eating Disorders ↗
Clinical-stage biopharma company Incannex Healthcare Ltd. (NASDAQ: IXHL) shared its quarterly activities report and appendix 4C for the period ended 30 September 2022, noticeably applying for several... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Good morning, investor! We're starting off Thursday with a breakdown of the biggest pre-market stock movers this morning! 
Via InvestorPlace
News headline image
Unrivaled Brands & Other Cannabis Operators Just Made Some Key Executive Changes You Should Know About ↗
As Benzinga Cannabis Capital Conference returns on September 13-14 to Chicago, gathering top CEOs, investors and leaders in the industry, let's scroll through the latest leadership changes within the... 
Via Benzinga
News headline image
Icannex Taps Ex Pfizer, FDA & Regulatory Affairs Expert ↗
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) appointed pharmaceutical executive Robert B. Clark to the board of directors. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Incannex Approved To Commence Phase 1 Clinical Trial Of CBD Based Anti-Inflammatory Drug ↗
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has received approval from the Bellberry Human Research Ethics Committee ('HREC') for a phase 1 clinical trial investigating its proprietary... 
Via Benzinga
News headline image
Incannex Reveals Clinical Trial Results On Dronabinol-Based Drug For Obstructive Sleep Apnea ↗
Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL), a clinical-stage pharmaceutical company developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for unmet... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday ↗
Gainers 
Via Benzinga
Incannex Announces Positive Pre-IND Meeting with U.S. FDA for IHL-42X for Obstructive Sleep Apnoea: Incannex Healthcare Limited (NASDAQ: IXHL)
Via Get News
Advancements for Anxiety, Sleep Apnea, Brain Injury, Lung Inflammation, Rheumatoid Arthritis & Inflammatory Bowel Disease: Incannex Healthcare Limited (NASDAQ: IXHL)
Via Get News
Topics Intellectual Property
Advancements for Anxiety, Sleep Apnea, Brain Injury, Lung Inflammation, Rheumatoid Arthritis & Inflammatory Bowel Disease: Incannex Healthcare Limited (NASDAQ: IXHL)
Via Viz Release
Topics Intellectual Property
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
On Wednesday, 29 stocks hit new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
On Thursday, 92 companies hit new 52-week lows. Areas of Interest About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
On Tuesday, 81 stocks hit new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Grupo Aval Acciones (NYSE:AVAL) was the biggest company by market cap to set a... 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.